Abstract
Monoclonal antibodies (MAbs) have been used for therapies and some analytical procedures as highly purified molecules. Many techniques have been applied and studied, focusing on monoclonal antibodies purification. In this study, an immobilized metal affinity chromatography membrane was developed and evaluated for the purification of anti-TNP IgG1 mouse MAbs from cell culture supernatant after precipitation with a 50% saturated ammonium sulfate solution. The chelating ligands iminodiacetic acid, carboxymethylated aspartic acid (CM-Asp), nitrilotriacetic acid, and tris (carboxymethyl) ethylenediamine in agarose gels with immobilized Ni(II) and Zn(II) ions were compared for the adsorption and desorption of MAbs. The most promising chelating ligand—CM-Asp—was then coupled to poly(ethylene vinyl alcohol) (PEVA) hollow fiber membranes. According to SDS-PAGE and ELISA analyses, a higher selectivity and a purification factor of 85.9 (fraction eluted at 500 mM Tris) were obtained for IgG1 using PEVA-CM-Asp-Zn(II). The anti-TNP MAb could be eluted under mild pH conditions causing no loss of antigen binding capacity.
Similar content being viewed by others
References
Köhler, G., & Milstein, C. (1975). Nature, 265, 495–497.
Tamashiro, W. M. S. C., & Augusto, E. F. P. (2008). Animal cell technology. In L. R. Castilho, A. M. Moraes & E. F. P. Augusto (Eds.), From biopharmaceuticals to gene therapy (pp. 409–434). London: Taylor & Francis.
Siberil, S., Dutertre, C. A., Boix, C., & Teillaud, J. L. (2005). Transfusion Clinique et Biologique, 12, 114–122.
Huse, K., Böhme, H. J., & Scholz, G. H. (2002). J Biochem Bioph Methods, 51, 217–231.
Reichert, J. M., Rosenwig, C. J., Faden, L. B., & Dewitz, M. C. (2005). Nature Biotechnology, 23, 1073–1078.
Sany, J. (2006). C R Biologies, 329, 228–240.
Walsh, G. (2006). Nat Biotechnology, 24, 769–778.
Luk, J. M., & Wong, K.-F. (2006). Clinical and Experimental Pharmacology and Physiology, 33, 482–488.
Kozlowski, S., & Swann, P. (2006). Adv Drug Delivery Rev, 58, 707–722.
Verdoliva, A., Pannone, F., Rossi, M., Catello, S., & Manfredi, V. (2002). J Immunol Methods, 271, 77–88.
Vijayalakshmi, M. A. (1989). Trends in Biotechnology, 7, 71–76.
Boschetti, E. (2001). J Biochem Biophis Methods, 49, 361–389.
Todorova-Balvay, D., Pitiot, O., Bourhim, M., Srikrishnan, T., & Vijayalakshmi, M. (2004). J Chromatogr B, 808, 57–62.
Yang, H., Gurgel, P. V., & Carbonell, R. G. (2005). J Peptide Res, 66, 120–137.
Porath, J., Carlsson, J., Olsson, I., & Belfrage, G. (1975). Nature, 258, 598–599.
Porath, J., & Olin, B. (1983). Biochemistry, 22, 1621–1630.
Vançan, S., Miranda, E. A., & Bueno, S. M. A. (2002). Process Biochemistry, 37, 573–579.
Serpa, G., Augusto, E. F. P., Tamashiro, W. M. S. C., Ribeiro, M. B., Miranda, E. A., & Bueno, S. M. A. (2005). J Chromatogr B, 816, 259–268.
Das, D., Allen, T. M., & Suresh, M. R. (2005). Protein Expression Purif, 39, 199–208.
Zimmerman, T., Frère, C. P., Satzger, M., Raba, M., Weisbach, M., Döhn, K., et al. (2006). J Immunol Methods, 314, 67–73.
Martins, S., Karmali, A., Andrade, J., & Serralheiro, M. (2006). Molecular Biotechnology, 33, 103–113.
Ribeiro, M. B., Vijayalakshmi, M., Todorova-Balvay, D., & Bueno, S. M. A. (2008). J Chromatogr B, 861, 64–73.
Platis, D., Drossard, J., Fisher, R., Ma, J. K.-C., & Labrou, N. E. (2008). J Chromatogr A, 1211, 80–89.
Ramessar, K., Rademacher, T., Sack, M., Stadlmann, J., Platis, D., Stiegler, G., et al. (2008). Proceedings of the National Academy of Sciences, 105, 3727–3732.
Gaberc-Porekar, V., & Menart, V. (2001). J Biochem Bioph Methods, 49, 335–360.
Gutiérrez, R., Martín del Valle, E. M., & Galán, M. A. (2007). Sep Purif Reviews, 36, 71–111.
Charcosset, C. (1998). J Chem Technol Biotechnol, 71, 95–110.
Tatárová, I., Gramblička, M., Antošová, M., & Polakovič, M. (2008). J Chromatogr A, 1193, 129–135.
Léo, P., Ucelli, P., Augusto, E. F. P., Oliveira, M. S., & Tamashiro, W. M. S. C. (2000). Hybridoma, 19, 473–478.
Mantovaara, T., Pertoft, H., & Porath, J. (1991). Biotechnology and Applied Biochemistry, 13, 315–322.
Bueno, S. M. A., Legallais, C., Haupt, K., & Vijayalakshmi, M. A. (1996). J Membr Sci, 117, 45–56.
El-Kak, A., & Vijayalakshmi, M. A. (1991). J Chromatogr, 570, 29–41.
Bradford, M. M. (1976). Analytical Biochemistry, 72, 248–254.
Laemmli, U. K. (1970). Nature, 227, 680–685.
Morrissey, J. H. (1981). Analytical Biochemistry, 117, 307–310.
Towbin, H., Staehelin, T., & Gordon, J. (1979). Proceedings of the National Academy of Sciences of the United States of America, 76, 4350–4354.
Chaga, G., Hopp, J., & Nelson, P. (1999). Biotechnology and Applied Biochemistry, 29, 19–24.
Hale, J. E., & Beidler, D. E. (1994). Analytical Biochemistry, 222, 29–33.
Johnson, R. D., & Arnold, F. H. (1995). Biotechnology and Bioengineering, 48, 437–443.
Bayramoglu, G., Celik, G., & Arica, M. Y. (2006). Colloids Surf A, 287, 75–85.
Yang, L., & Chen, P. (2002). J Memb Sci, 205, 141–153.
Sharma, S., & Agarwal, G. P. (2001). Analytical Biochemistry, 288, 126–140.
Acknowledgments
The authors gratefully acknowledge the financial support of FAPESP—Fundação de Amparo à Pesquisa do Estado de São Paulo—SP, Brazil and CNPq—Conselho Nacional de Desenvolvimento Científico e Tecnológico—Brasília, DF, Brazil.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bresolin, I.T.L., Borsoi-Ribeiro, M., Tamashiro, W.M.S.C. et al. Evaluation of Immobilized Metal-Ion Affinity Chromatography (IMAC) as a Technique for IgG1 Monoclonal Antibodies Purification: The Effect of Chelating Ligand and Support. Appl Biochem Biotechnol 160, 2148–2165 (2010). https://doi.org/10.1007/s12010-009-8734-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-009-8734-5